IVD Market in BRIC by Application (Infectious Diseases, Diabetes, Cardiology), Product & Service (Software, Instruments, Reagents), Technology (Microbiology, Immunoassay, Hematology), Country (India, China, Brazil, Russia) – 2021 to 2026

$3,850.00$5,850.00

Published on: April 2, 2021
Clear
SKU: GMS-1342 Category:

OVERVIEW

The global market for in vitro diagnostics is forecast to grow over the forecast period at a CAGR of 5.33%. The rising demand for early and accurate diagnosis of disease, increased prevalence of infectious diseases, rising adoption of fully automated tools and automation in laboratories, growing acceptance of point-of-care testing, and increased awareness of personalized medicine are key drivers of market growth. The report discusses in detail the impact of COVID-19 on market for the year 2020 and beyond.

IVD Market in BRIC by Application (Infectious Diseases, Diabetes, Cardiology), Product & Service (Software, Instruments, Reagents), Technology (Microbiology, Immunoassay, Hematology), Country (India, China, Brazil, Russia) – 2021 to 2026 1

IVD Market in BRIC by Application (Infectious Diseases, Diabetes, Cardiology), Product & Service (Software, Instruments, Reagents), Technology (Microbiology, Immunoassay, Hematology), Country (India, China, Brazil, Russia) – 2021 to 2026 2

IVD Market in BRIC by Application (Infectious Diseases, Diabetes, Cardiology), Product & Service (Software, Instruments, Reagents), Technology (Microbiology, Immunoassay, Hematology), Country (India, China, Brazil, Russia) – 2021 to 2026 3

IVD Market in BRIC by Application (Infectious Diseases, Diabetes, Cardiology), Product & Service (Software, Instruments, Reagents), Technology (Microbiology, Immunoassay, Hematology), Country (India, China, Brazil, Russia) – 2021 to 2026 4

IVD Market in BRIC by Application (Infectious Diseases, Diabetes, Cardiology), Product & Service (Software, Instruments, Reagents), Technology (Microbiology, Immunoassay, Hematology), Country (India, China, Brazil, Russia) – 2021 to 2026 5

IVD Market in BRIC by Application (Infectious Diseases, Diabetes, Cardiology), Product & Service (Software, Instruments, Reagents), Technology (Microbiology, Immunoassay, Hematology), Country (India, China, Brazil, Russia) – 2021 to 2026 6

IVD Market in BRIC by Application (Infectious Diseases, Diabetes, Cardiology), Product & Service (Software, Instruments, Reagents), Technology (Microbiology, Immunoassay, Hematology), Country (India, China, Brazil, Russia) – 2021 to 2026 7

IVD Market in BRIC by Application (Infectious Diseases, Diabetes, Cardiology), Product & Service (Software, Instruments, Reagents), Technology (Microbiology, Immunoassay, Hematology), Country (India, China, Brazil, Russia) – 2021 to 2026 8
IVD Market in BRIC by Application (Infectious Diseases, Diabetes, Cardiology), Product & Service (Software, Instruments, Reagents), Technology (Microbiology, Immunoassay, Hematology), Country (India, China, Brazil, Russia) – 2021 to 2026 7

TABLE OF CONTENT

1 Global IVD Market in BRIC
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global IVD Market in BRIC – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global IVD Market in BRIC – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global IVD Market in BRIC – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global IVD Market in BRIC – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global IVD Market in BRIC – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global IVD Market in BRIC – By Product & Service (Market Size – & million/billion)
8.1 Reagents & Kits
8.2 Instruments
8.3 Services
8.4 Data Management Software

9 Global IVD Market in BRIC – By Technology
9.1 Clinical Chemistry
9.2 Immunochemistry/Immunoassay
9.3 Hematology
9.4 Coagulation & Hemostasis
9.5 Clinical Microbiology
9.6 Molecular Diagnostics (MDx)
9.7 Other

10 Global IVD Market in BRIC – By Application
10.1 Diabetes
10.2 Infectious Diseases
10.3 Oncology/Cancer
10.4 Cardiology
10.5 Nephrology
10.6 Other

11 Global IVD Market in BRIC – By End-User
11.1 Hospital-based Laboratories
11.2 Clinical/Reference Laboratories
11.3 Academic Institutes
11.4 Point-of-care Testing
11.5 Patient Self-Testing
11.6 Other

12 Global IVD Market in BRIC – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global IVD Market in BRIC – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global IVD Market in BRIC Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Roche Diagnostics
14.3 Abbott Laboratories, Inc.
14.4 Becton, Dickinson and Company
14.5 Ortho-Clinical Diagnostics, Inc.
14.6 Qiagen N.V.
14.7 Sysmex Corporation
14.8 Danaher Corporation
14.9 Johnson & Johnson Services, Inc.
14.10 Biomérieux SA
14.11 Bio-Rad Laboratories, Inc.
14.12 Company 11 & more

15 Global IVD Market in BRIC – Appendix
15.1 Sources
15.2 Abbreviations